Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-labeled, non-comparative study to examine the safety and
efficacy of ASP1585 for long-term dosing in chronic kidney disease and hyperphosphatemia
patients on hemodialysis.